Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up

Published:2017-05 Issue:5 Volume:19 Page:449-457
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Ohman Kerri A.,Liu Jingxia,Linehan David C.,Tan Marcus C.,Tan Benjamin R.,Fields Ryan C.,Strasberg Steven M.,Hawkins William G.

Funder

Washington University Surgical Oncology Training

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection;Kalser;Arch Surg,1985

2. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer;Gastrointestinal Tumor Study Group;Cancer,1987

3. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma;Nukui;Am J Surg,2000

4. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma;Picozzi;Am J Surg,2003

5. Interferon-based adjuvant chemoradiation for resected pancreatic head cancer: long-term follow-up of the Virginia Mason protocol;Rocha;Ann Surg,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22

2. Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment;Seminars in Cancer Biology;2022-11

3. Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs;Frontiers in Genetics;2022-09-14

4. Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer;International Journal of Oncology;2022-07-01

5. IFNA pathway drives the more aggressive phenotype of KRAS^G12D-mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3